Kelly Gorres

892 total citations
12 papers, 735 citations indexed

About

Kelly Gorres is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Kelly Gorres has authored 12 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Kelly Gorres's work include Viral-associated cancers and disorders (6 papers), HIV/AIDS drug development and treatment (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Kelly Gorres is often cited by papers focused on Viral-associated cancers and disorders (6 papers), HIV/AIDS drug development and treatment (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Kelly Gorres collaborates with scholars based in United States, Poland and Italy. Kelly Gorres's co-authors include Ronald T. Raines, George Miller, Grant R. Krow, David Tuck, L Gradoville, Vincent Schulz, Urszula Derewenda, Minmin Yu, A. Joachimiak and David R. Cooper and has published in prestigious journals such as PLoS ONE, Biochemistry and Analytical Biochemistry.

In The Last Decade

Kelly Gorres

12 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Gorres United States 10 392 142 115 66 58 12 735
Guojin Huang China 19 422 1.1× 168 1.2× 196 1.7× 88 1.3× 22 0.4× 44 899
Chao Yuan China 19 364 0.9× 174 1.2× 53 0.5× 67 1.0× 27 0.5× 76 971
Caiqin Zhang China 20 346 0.9× 80 0.6× 131 1.1× 117 1.8× 35 0.6× 48 1.2k
Qinqin Jiang China 16 460 1.2× 139 1.0× 115 1.0× 56 0.8× 112 1.9× 44 1.1k
Jonathan P. Schuermann United States 18 864 2.2× 68 0.5× 107 0.9× 145 2.2× 15 0.3× 25 1.2k
Zechen Chong United States 16 1.1k 2.9× 209 1.5× 123 1.1× 66 1.0× 19 0.3× 32 1.6k
Anja Lüth Germany 14 675 1.7× 81 0.6× 156 1.4× 67 1.0× 11 0.2× 26 1.0k

Countries citing papers authored by Kelly Gorres

Since Specialization
Citations

This map shows the geographic impact of Kelly Gorres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Gorres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Gorres more than expected).

Fields of papers citing papers by Kelly Gorres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Gorres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Gorres. The network helps show where Kelly Gorres may publish in the future.

Co-authorship network of co-authors of Kelly Gorres

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Gorres. A scholar is included among the top collaborators of Kelly Gorres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Gorres. Kelly Gorres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Gorres, Kelly, Markus Reineke, & George Miller. (2024). Transcriptome analysis of Burkitt lymphoma cells treated with anti-convulsant drugs that are inhibitors of Epstein–Barr virus lytic reactivation. PLoS ONE. 19(4). e0299198–e0299198. 3 indexed citations
2.
Gorres, Kelly, et al.. (2020). Inhibition of Epstein‐Barr Virus by Serotonin‐Dopamine Antagonists. The FASEB Journal. 34(S1). 1–1. 2 indexed citations
3.
Gorres, Kelly, et al.. (2019). Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine. Viruses. 11(5). 450–450. 17 indexed citations
4.
Ornaghi, Sara, John N. Davis, Kelly Gorres, et al.. (2016). Mood stabilizers inhibit cytomegalovirus infection. Virology. 499. 121–135. 14 indexed citations
5.
Gorres, Kelly, et al.. (2016). Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus. mBio. 7(2). e00113–e00113. 18 indexed citations
6.
Gorres, Kelly, et al.. (2014). Activation and Repression of Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycles by Short- and Medium-Chain Fatty Acids. Journal of Virology. 88(14). 8028–8044. 54 indexed citations
7.
Gradoville, L, et al.. (2011). Valproic Acid Antagonizes the Capacity of Other Histone Deacetylase Inhibitors To Activate the Epstein-Barr Virus Lytic Cycle. Journal of Virology. 85(11). 5628–5643. 39 indexed citations
8.
Gorres, Kelly & Ronald T. Raines. (2010). Prolyl 4-hydroxylase. Critical Reviews in Biochemistry and Molecular Biology. 45(2). 106–124. 486 indexed citations
9.
Gorres, Kelly, et al.. (2009). Stringency of the 2-His–1-Asp Active-Site Motif in Prolyl 4-Hydroxylase. PLoS ONE. 4(11). e7635–e7635. 22 indexed citations
10.
Derewenda, Urszula, Tomasz Boczek, Kelly Gorres, et al.. (2009). Structure and Function of Bacillus subtilis YphP, a Prokaryotic Disulfide Isomerase with a CXC Catalytic Motif,. Biochemistry. 48(36). 8664–8671. 29 indexed citations
11.
Gorres, Kelly & Ronald T. Raines. (2008). Direct and continuous assay for prolyl 4-hydroxylase. Analytical Biochemistry. 386(2). 181–185. 18 indexed citations
12.
Gorres, Kelly, et al.. (2008). Conformational Preferences of Substrates for Human Prolyl 4-Hydroxylase. Biochemistry. 47(36). 9447–9455. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026